Restless legs syndrome: A clinical update

Chest

Volumn 130, Issue 5, 2006, Pages 1596-1604

  Gamaldo, Charlene E ^a   Earley, Christopher J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diagnosis; Parkinson disease; Restless legs syndrome; Treatment

Indexed keywords

ANTICONVULSIVE AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; CARBIDOPA PLUS LEVODOPA; CLONAZEPAM; CODEINE; DEXTROPROPOXYPHENE; DIPHENHYDRAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; FERRIC GLUCONATE; FERRITIN; GABAPENTIN; HYDROCODONE; IRON; LEVODOPA; METHADONE; METOCLOPRAMIDE; NEUROLEPTIC AGENT; OPIATE; OXYCODONE; PERGOLIDE; PRAMIPEXOLE; PROCHLORPERAZINE MALEATE; ROPINIROLE; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRANSFERRIN; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ANAPHYLAXIS; ARTICLE; CIRCADIAN RHYTHM; CONSTIPATION; DISEASE EXACERBATION; HUMAN; IRON BLOOD LEVEL; NEUROPATHY; PARESTHESIA; PARKINSON DISEASE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT;

EID: 33751229032     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.130.5.1596     Document Type: Article

References (84)

1. Hening W, Montplaisir J, Walters A, et al. Impact of restless legs syndrome (RLS) on sleep: the REST (RLS Epidemiology, Symptoms and Treatment) Study in Primary Care. Sleep 2003; 26:A332
2. Hening W, Walters AS, Allen RP, et al. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med 2004; 5:237-246
3. Hogl B, Kiechl S, Willeit J, et al. Restless legs syndrome: a community-based study of prevalence, severity, and risk factors. Neurology 2005; 64:1920-1924
4. Bjorvatn B, Leissner L, Ulfberg J, et al. Prevalence, severity and risk factors of restless legs syndrome in the general adult population in two Scandinavian countries. Sleep Med 2005; 6:307-312
5. Allen RP, Earley CJ. Resdess legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol 2001; 18:128-147
6. Sevim S, Dogu O, Camdeviren H, et al. Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey. Neurology 2003; 61:1562-1569
7. Tan EK, Seah A, See SJ, et al. Restless legs syndrome in an Asian population: a study in Singapore. Mov Disord 2001; 16:577-579
8. Kageyama T, Kabuto M, Nitta H, et al. Prevalences of periodic limb movement-like and restless legs-like symptoms among Japanese adults. Psychiatry Clin Neurosci 2000; 54:296-298
9. Kutner NG, Bliwise DL. Restless legs complaint in African-American and Caucasian hemodialysis patients. Sleep Med 2002; 3:497-500
10. Dinwiddie LC. Restless legs syndrome: not just a problem for dialysis patients. ANNA J 1997; 24:655-662
11. Berger K, Luedemann J, Trenkwalder C, et al. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 2004; 164:196-202
12. Lee KA, Zaffke ME, Baratte-Beebe K. Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron. J Womens Health Gend Based Med 2001; 10:335-341
13. Merlino G, Piani A, Dolso P, et al. Sleep disorders in patients with end-stage renal disease undergoing dialysis therapy. Nephrol Dial Transplant 2006; 21:184-190
14. Manconi M, Govoni V, De Vito A, et al. Restless legs syndrome and pregnancy. Neurology 2004; 63:1065-1069
15. Manconi M, Govoni V, De Vito A, et al. Pregnancy as a risk factor for restless legs syndrome. Sleep Med 2004; 5:305-308
16. Manconi M, Ferini-Strambi L. Restless legs syndrome among pregnant women. Sleep 2004; 27:350; author reply 351
17. Ondo WG, Vuong KD, Jankovic J. Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 2002; 59:421-424
18. Gemignani F, Marbini A, Di Giovanni G, et al. Charcot-Marie-tooth disease type 2 with restless legs syndrome. Neurology 1999; 52:1064-1066
19. Schols L, Haan J, Riess O, et al. Sleep disturbance in spinocerebellar ataxias: is the SCA3 mutation a cause of restless legs syndrome? Neurology 1998; 51:1603-1607
20. Walters A. Restless legs syndrome and lumbosacral radiculopathy. Sleep Res 1996; 25:385
21. Montplaisir J, Boucher S, Poirier G, et al. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 1997; 12:61-65
22. Ondo W, Jankovic J. Restless legs syndrome: clinicoetiologic correlates. Neurology 1996; 47:1435-1441
23. Bonati MT, Ferini-Strambi L, Aridon P, et al. Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain 2003; 126:1485-1492
24. Chen S, Ondo WG, Rao S, et al. Genomewide linkage scan identifies a novel susceptibility locus for restless legs syndrome on chromosome 9p. Am J Hum Genet 2004; 74:876-885
25. Winkelmann J, Lichtner P, Putz B, et al. Evidence for further genetic locus heterogeneity and confirmation of RLS-1 in restless legs syndrome. Mov Disord 2006; 21:28-33
26. Allen RP, Earley CJ. Defining the phenotype of the restless legs syndrome (RLS) using age-of-symptom-onset. Sleep Med 2000; 1:11-19
27. Polydefkis M, Allen RP, Hauer P, et al. Subclinical sensory neuropathy in late-onset restless legs syndrome. Neurology 2000; 55:1115-1121
28. Turjanski N, Lees AJ, Brooks DJ. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies. Neurology 1999; 52:932-937
29. Michaud M, Soucy JP, Chabli A, et al. SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep. J Neurol 2002; 249:164-170
30. Staedt J, Stoppe G, Kogler A, et al. Single photon emission tomography (SPET) imaging of dopamine D2 receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS). J Neural Transm Gen Sect 1995; 99:187-193
31. Tribl GG, Asenbaum S, Klosch G, et al. Normal IPT and IBZM SPECT in drug naive and levodopa-treated idiopathic restless legs syndrome. Neurology 2002; 59:649-650
32. Eisensehr I, Wetter TC, Linke R, et al. Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome. Neurology 2001; 57:1307-1309
33. Allen RP, Barker PB, Wehrl F, et al. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 2001; 56:263-265
34. Gelman N, Gorell JM, Barker PB, et al. MR Imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology 1999; 210:759-767
35. Connor JR, Wang XS, Patton SM, et al. Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome. Neurology 2004; 62:1563-1567
36. Clardy SL, Earley CJ, Allen RP, et al. Ferritin subunits in CSF are decreased in restless legs syndrome. J Lab Clin Med 2006; 147:67-73
37. Mizuno S, Mihara T, Miyaoka T, et al. CSF iron, ferritin and transferrin levels in restless legs syndrome. J Sleep Res 2005; 14:43-47
38. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology; a report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4:101-119
39. Hening WA, Walters AS, Wagner M, et al. Circadian rhythm of motor restlessness and sensory symptoms in the idiopathic restless legs syndrome. Sleep 1999; 22:901-912
40. Cheshire WP Jr. Hypotensive akathisia: autonomic failure associated with leg fidgeting while sitting. Neurology 2000; 55:1923-1926
41. Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res 2002; 53:547-554
42. Phillips B, Young T, Finn L, et al. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000; 160:2137-2141
43. Tison F, Crochard A, Leger D, et al. Epidemiology of restless legs syndrome in French adults: a nationwide survey: the INSTANT study. Neurology 2005; 65:239-246
44. Walters AS, Aldrich MA, Allen RP, et al. Towards a better definition of the restless legs syndrome. Mov Disord 1995; 10:634-642
45. Hening W, Allen R, Earley C, et al. The treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine review. Sleep 1999; 22:970-999
46. Chervin RD. Periodic leg movements and sleepiness in patients evaluated for sleep-disordered breathing. Am J Respir Crit Care Med 2001; 164:1454-1458
47. Exar EN, Collop NA. The association of upper airway resistance with periodic limb movements. Sleep 2001; 24:188-192
48. Hornyak M, Riemann D, Voderholzer U. Do periodic leg movements influence patients' perception of sleep quality? Sleep Med 2004; 5:597-600
49. Haba-Rubio J, Staner L, Krieger J, et al. Periodic limb movements and sleepiness in obstructive sleep apnea patients. Sleep Med 2005; 6:225-229
50. Michaud M, Paquet J, Lavigne G, et al. Sleep laboratory diagnosis of restless legs syndrome. Eur Neurol 2002; 48:108-113
51. Allen RP, Dean T, Earley CJ. Effects of rest-duration, time-of-day and their interaction on periodic leg movements while awake in restless legs syndrome. Sleep Med 2005; 6:429-434
52. Sun ER, Chen CA, Ho G, et al. Iron and the restless legs syndrome. Sleep 1998; 21:371-377
53. Haba-Rubio J, Staner L, Petiau C, et al. Restless legs syndrome and low brain iron levels in patients with haemochromatosis. J Neurol Neurosurg Psychiatry 2005; 76:1009-1010
54. Brandhagen DJ, Fairbanks VF, Baldus W. Recognition and management of hereditary hemochromatosis. Am Fam Physician 2002; 65:853-860
55. Hening WA, Allen RP, Earley CJ, et al. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep 2004; 27:560-583
56. Silber MH, Ehrenberg BL, Allen RP, et al. An algorithm for the management of restless legs syndrome. Mayo Clin Proc 2004; 79:916-922
57. Earley CJ. Restless legs syndrome. N Engl J Med 2003; 348:2103-2109
58. Plowman BK, Boggie DT, Morreale AP, et al. Sleep attacks in patients receiving dopamine-receptor agonists. Am J Health Syst Pharm 2005; 62:537-540
59. Bassetti C, Clavadetscher S, Gugger M, et al. Pergolide-associated 'sleep attacks' in a patient with restless legs syndrome. Sleep Med 2002; 3:275-277
60. Giovannoni G, O'Sullivan JD, Turner K, et al. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 2000; 68:423-428
61. Allen RP, Earley CJ. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 1996; 19:205-213
62. Garcia-Borreguero D. Augmentation: understanding a key feature of RLS. Sleep Med 2004; 5:5-6
63. Agarwal P, Fahn S, Frucht SJ. Diagnosis and management of pergolide-induced fibrosis. Mov Disord 2004; 19:699-704
64. Tintner R, Manian P, Gauthier P, et al. Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson disease. Arch Neurol 2005; 62:1290-1295
65. Walters AS. Review of receptor agonist and antagonist studies relevant to the opiate system in restless legs syndrome. Sleep Med 2002; 3:301-304
66. Walters AS, Winkelmann J, Trenkwalder C, et al. Long-term follow-up on restless legs syndrome patients treated with opioids. Mov Disord 2001; 16:1105-1109
67. Happe S, Klosch G, Saletu B, et al. Treatment of idiopathic restless legs syndrome (RLS) with gabapentin. Neurology 2001; 57:1717-1719
68. Garcia-Borreguero D, Larrosa O, de la Llave Y, et al. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology 2002; 59:1573-1579
69. Adler CH. Treatment of restless legs syndrome with gabapentin. Clin Neuropharmacol 1997; 20:148-151
70. Mellick GA, Mellick LB. Management of restless legs syndrome with gabapentin (neurontin). Sleep 1996; 19:224-226
71. Staedt J, Stoppe G, Riemann H, et al. Lamotrigine in the treatment of nocturnal myoclonus syndrome (NMS): two case reports. J Neural Transm 1996; 103:355-361
72. Youssef EA, Wagner ML, Martinez JO, et al. Pilot trial of lamotrigine in the restless legs syndrome [letter]. Sleep Med 2005; 6:89
73. Walters A. Is there a subpopulation of children with growing pains who really have restless legs syndrome? A review of the literature. Sleep Med 2002; 3:93-98
74. Rajaram SS, Walters AS, England SJ, et al. Some children with growing pains may actually have restless legs syndrome. Sleep 2004; 27:767-773
75. Konofal E, Lecendreux M, Arnulf I, et al. Iron deficiency in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 2004; 158:1113-1115
76. Konofal E, Lecendreux M, Arnulf I, et al. Restless legs syndrome and serum ferritin levels in ADHD children. Sleep 2003; 26:A136
77. Konofal E, Lecendreux M, Bouvard MP, et al. High levels of nocturnal activity in children with attention-deficit hyperactivity disorder: a video analysis. Psychiatry Clin Neurosci 2001; 55:97-103
78. Kotagal S, Silber MH. Childhood-onset restless legs syndrome. Ann Neurol 2004; 56:803-807
79. Walters AS, Mandelbaum DE, Lewin DS, et al. Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Pediatr Neurol 2000; 22:182-186
80. Konofal E, Arnulf I, Lecendreux M, et al. Ropinirole in a child with attention-deficit hyperactivity disorder and restless legs syndrome. Pediatr Neurol 2005; 32:350-351
81. Crawford TO, Mitchell WG, Snodgrass SR. Lorazepam in childhood status epilepticus and serial seizures: effectiveness and tachyphylaxis. Neurology 1987; 37:190-195
82. Hain RD, Miser A, Devins M, et al. Strong opioids in pediatric palliative medicine. Paediatr Drugs 2005; 7:1-9
83. Nygaard T, Marsden D, Fahn S. Dop-responsive dystonia: long-term treatment response and prognosis. Neurol 1991; 41:174-181
84. Pellock JM, Watemberg N. New antiepileptic drugs in children: present and future. Semin Pediatr Neurol 1997; 4:9-18